4.7 Meeting Abstract

Patient Satisfaction with 20% Subcutaneous Immunoglobulin (Hizentra®) Treatment: Results From a Single-Center Study in Children with Immunodeficiencies

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 131, Issue 2, Pages AB155-AB155

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2012.12.1214

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available